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Background: Cervical Cancer (CC) is the number one cancer among women in sub-Saharan Africa. Although CC is
preventable, most women in developing countries do not have access to screening.
Methods: This cross-sectional study was conducted to determine the prevalence and risk factors for cervical lesions
using visual inspection with acetic acid (VIA) among 112 HIV positive and 161 negative women aged 18–69 years.
Results: The presence of cervical lesions was greater among HIV positive (22.9%) than HIV negative women (5.7%;
p < 0.0001). In logistic models, the risk of cervical lesions among HIV positive women was 5.24 times higher when
adjusted by age (OR 5.24, CI 2.31–11.88), and 4.06 times higher in a full model (OR 4.06, CI 1.61–10.25), than among
HIV negative women. In the age-adjusted model women who had ≥2 lifetime sexual partners were 3 times more
likely (OR 3.00, CI 1.02–8.85) to have cervical lesions compared to women with one lifetime partner and the odds of
cervical lesions among women with a history of STIs were 2.16 greater (OR 2.16, CI 1.04–4.50) than among women
with no previous STI. In the fully adjusted model women who had a previous cervical exam were 2.5 times more
likely (OR 2.53, CI 1.06–6.05) to have cervical lesions than women who had not.
Conclusions: The high prevalence of HIV infection and the strong association between HIV and cervical lesions
highlight the need for substantial scale-up of cervical screening to decrease the rate of CC in Swaziland.
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Cervical cancer (CC) is the fourth most common cancer
in women worldwide and the number one cancer among
women in sub-Saharan Africa. There were an estimated
528,000 new CC cases worldwide in 2012 and 266,000
CC deaths [1]. About 84% of the global burden of CC
occurs in less developed countries with limited resources
[1]. Although CC is preventable, most women in
resource-poor countries do not have access to a screen-
ing program. Gakidou et al. reported that on average CC
screening coverage in developing countries is 19% com-
pared to 63% in developed countries; rates as low as 1%* Correspondence: jollyp@uab.edu
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CC is primarily caused by the Human Papillomavirus
(HPV; [3]). In women with healthy immune systems,
most HPV infections are transient and cleared. However,
CC is four to five times more prevalent among women
who are HIV-positive [4]. Several studies clearly show an
increased risk of precancerous cervical lesions and
possibly more rapid progression to cancer among HIV
positive women. Compared with HIV negative women,
HIV positive women are more likely to be infected with
HPV and to have persistent HPV leading to pre-cancer,
larger and more difficult to treat precancerous lesions,
higher recurrence rates of pre-cancer following treatment,
and precancerous lesions that progress more rapidly to
invasive cancer [5–7]. Invasive CC and its precursor,
cervical intraepithelial neoplasia (CIN), are associated withle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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of HPV [8]. The highest burden of HIV/AIDS is in sub-
Saharan Africa and more than half of infected people are
women with little or no access to CC screening.
Swaziland’s HIV prevalence of 27.4% is the highest in the
world [9] and women aged 15–49 years make up more
than half of all those infected; HIV prevalence among
pregnant women is estimated at 39.2% [10].
An unpublished study titled Female Reproductive
Cancer Awareness conducted in Swaziland in 2009 by the
Swaziland Breast and Cervical Cancer Network (SBCCN)
revealed that CC was the most common cause of cancer-
related hospital admissions among Swazi women. This is
most likely due to the high prevalence of HIV among
women in the country. According to the latest WHO data
published in May 2014, CC Deaths in Swaziland reached
112 or 0.83% of total deaths [11]. Cytology-based screen-
ing, as used in high-income countries, is currently not
feasible in Swaziland because of the financial, infrastruc-
ture, human resources and technological investments re-
quired to sustain such a program. Visual Inspection with
Acetic Acid (VIA) is an evidence-based alternative
approach to cytology-based screening for CC in low-
resource settings. Studies have reported that the sensitivity
of VIA (77%; range 56–94%) for detecting precancerous
lesions is comparable to, or greater than, cervical cytology
(60%; range 35–84%), while requiring less resources [12].
In addition, VIA provides immediate results, thus promot-
ing linkage of screening with treatment. VIA combined
with cryotherapy (freezing of precancerous cervical le-
sions), ideally in a single visit approach (SVA), is an effect-
ive and efficient strategy for secondary prevention of CC
in low-resource settings, and can be conducted by compe-
tent clinicians and nurses [13]. This linkage of screening
with treatment has contributed to VIA-based programs
demonstrating a reduction in precancerous lesions, CC
incidence, and mortality [12].
In 2010, the SBCCN in partnership with an inter-
national donor and the Ministry of Health launched the
first three dedicated CC ‘screen and treat’ clinics in the
country at the Raleigh Fitkin Memorial Hospital in
Manzini, the Mbabane Government Hospital, and the
Hlatikulu Government Hospital which has allowed cer-
vical screening for a number of women. Unfortunately,
many cases are late-stage diagnosis with very poor prog-
nosis. CC not only significantly increases health care
cost, it also places huge financial constraints on the
families of affected women due to extensive treatment,
supportive care costs, and loss of income. Additionally, it
results in significant emotional distress for the families.
Since CC is preventable, identifying potential factors
that increase women’s risk for cervical lesions is essential
to developing programs that empower women to prac-
tice risk-reducing behaviours. Based on the literature,factors such as, younger age at sexual initiation, multiple
sexual partners, higher number of recent sexual part-
ners, tobacco use, immune suppression such as caused
by HIV infection, high parity, long-term oral contracep-
tive use and infection with other sexually transmitted
infections have been identified as risk factors for CC
[8, 14–16]. Further, factors such as knowledge and atti-
tude towards screening, as well as availability and accessi-
bility of services determine the extent to which women
will participate in screening and other health services [17].
This cross-sectional study was designed to investigate
the prevalence and risk factors for CC among HIV posi-
tive women in Swaziland. With a better understanding
of the epidemiology of CC in Swaziland health promo-
tion activities that address modifiable risk behaviors and
motivate women to take measures to reduce their risk
for CC can be developed. Additionally, the results of the
study can be used to guide the development of policies
and health service delivery related to preventing cervical
cancer. The specific objectives of the study were to: 1)
estimate the prevalence of cervical lesions/cancer by
screening a sample of HIV positive and HIV negative
women for cervical lesions/cancer using VIA; 2) Assess
the association between socio-demographic factors and
CC among the women; and 3) determine the association
between sexual and reproductive history and CC among
the women.
Methods
Study design and study site
A cross-sectional study was conducted among HIV posi-
tive and HIV negative women aged 18–69 years. The
women were recruited from three hospitals in three re-
gions of Swaziland that provided VIA and cryotherapy,
namely, the Mbabane Hospital in the Hhohho Region,
the Raliegh Fitkin Memorial (RFM) Hospital in the
Manzini Region, and the Hlatikulu Hospital in the Shi-
selweni Region. These are all regional referral hospitals
although Mbabane is a national referral hospital. These
were the only facilities with VIA and cryotherapy ser-
vices at the time of the study although such services
have since been scaled up. HIV patients were selected
from antiretroviral therapy (ART) clinics and from
among patients who tested HIV positive at HIV care and
treatment (HTC) sites at the out-patient departments
(OPDs) of the hospitals. The comparison group were
women who tested HIV negative at the OPDs.
Recruitment and data collection
Potential participants were informed of the study by the
clinic staff and those who expressed interest in partici-
pating were introduced to the study staff by the clinic
staff. The study staff then told the women about the pur-
pose and procedures of the study. The women were
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could refuse to participate and could withdraw from the
study at any time. Women 18–69 years who lived in the
specific region and did not have cervical complaints
were eligible to participate in the study; cases had to be
HIV-positive and controls had to be HIV-negative. Preg-
nant women and women who were less than 12 weeks
postpartum were excluded until they were greater than
12 weeks postpartum. Women who expressed interest in
the study were asked to read the informed consent and
to ask questions before signing the form. After providing
informed consent, a questionnaire was administered
by trained interviewers to collect data on:1) Socio-
demographic and lifestyle characteristics (age, sex, marital
status, income, education, occupation, smoking, substance
and alcohol abuse); and 2) Sexual and reproductive prac-
tices (condom use, multiple partners, age of sexual initi-
ation, age at first child). A unique participant ID number
was placed on each questionnaire instead of personal
identifying information. The interviews were conducted in
private hospital rooms to ensure confidentiality and took
approximately 45 min to complete. After the interview
each woman was screened for cervical lesions by a trained
clinic staff member using VIA. A woman was considered
VIA positive if there was a thick, dense white lesion with
distinct borders located within the transformation zone
of the cervix and close to or touching the squamocol-
umnar junction (SCJ; [18]). The study protocol was
reviewed and approved by the Institutional Review
Board of the University of Alabama at Birmingham and
the Scientific and Ethics Committee of the Ministry
of Health and Social Welfare, Kingdom of Swaziland,
prior to implementation.
Data analysis
Data were analyzed for 273 women (112 HIV-positive
and 161 HIV-negative) aged 18–69 years.
VIA results were available for 271 of the women but
HIV status is not available for three. Socio-demographic
and sexual and reproductive history variables were tabu-
lated for HIV positive and negative and VIA positive and
negative women. Descriptive statistics (frequencies, per-
centages, means) were performed on all variables and
used to summarize the socio-demographic and sexual
and reproductive history data for the study groups. Dif-
ferences among the variables for the groups were com-
pared using Chi-square and t-test analyses. Variables
that were associated with cervical lesions and other rele-
vant variables were used to create multivariate models.
Logistic regression was used to estimate odds ratios and
95% confidence intervals for the risk of cervical lesions
based on VIA results and other significant sexual history
variables, adjusting for socio-demographic variables. SAS
9.4 (SAS institute, Cary, NC) software was used for theanalysis and all statistical tests of a two-sided p-value of
<0.05 were considered significant.
Results
When bivariate analysis was conducted between sociode-
mographic variables and HIV status, significant associa-
tions were found between HIV status and age, income,
and level of education (Table 1). A higher proportion of
HIV positive women were ≥age 30 years compared with
HIV negative women (p = 0.04). On the contrary, a
higher proportion of HIV negative women earned higher
income (>E1201) per month (p = 0.03) and had a higher
level of education than HIV positive women (p <0.01).
With regard to cervical lesions, four times as many HIV
positive women (22.9%) compared with HIV negative
women (5.7%) had cervical lesions (p <0.01) based on
VIA results. When bivariate analysis was conducted be-
tween sociodemographic and sexual and reproductive
history variables and VIA status none of the socio-
demographic variables was significantly associated with
presence of cervical lesions (Table 2). However, there
were significant associations between the number of life-
time sexual partners and the presence of cervical lesions
(p = 0.03), and between VIA and HIV status (Table 2). A
significantly higher proportion of VIA positive women
(73.5%) were HIV positive compared with HIV negative
women (35.96%; p <0.01). A marginal association was
observed between a history of STI and the presence of
cervical lesions (p = 0.05). Although cervical lesions did
not differ according to age at first sexual intercourse or
age at first child, a substantial portion of the women
(40.6%) had their first sexual intercourse at or below age
17 years (48.6% of women with cervical lesions and
39.4% of women without). The age at first child was at
or below 17 years for 35.8% of the women.
Table 3 shows the results of age adjusted and fully ad-
justed logistic models for sociodemographic and sexual
and reproductive history variables listed in Tables 1 and
2 and cervical lesions. In both models, HIV was found
to be a significant predictor for having cervical lesions.
The risk of cervical lesions among HIV positive women
was 5 times greater in the age-adjusted model (OR 5.24,
CI 2.31–11.88) and 4 times greater in the full model
(OR 4.06, CI 1.61–10.25) than among HIV negative
women. In the age-adjusted model, number of lifetime
sexual partners and history of STI were significant pre-
dictors of having cervical lesions. Women who had two
or more lifetime sexual partners were 3 times more
likely to have cervical lesions (OR 3.00, CI1.02–8.85)
compared to women with one lifetime partner. Women
who had been diagnosed with a STI were 2 times more
likely to have cervical lesions (OR 2.16, CI 1.04–4.50)
than women who had not previously been diagnosed
with a STI. In the fully adjusted model, previous cervical










N (%) N (%) N (%) N (%)
Age
<30 32 (28.6) 65 (40.4) 0.04 11 (31.4) 75 (31.8) 0.97
≥30 80 (71.4) 94 (59.6) 24 (68.6) 161 (68.2)
Region
Hhohho 41 (36.6) 67 (42.4) 0.77 18 (51.4) 92 (39.5) 0.11
Lubombo 3 (2.7) 4 (2.5) 2 (5.7) 5 (2.1)
Manzini 56 (50.0) 69 (43.7) 14 (40.0) 106 (45.5)
Shiselwenni 12 (10.7) 18 (11.4) 1 (2.9) 30 (12.9)
Had previous cervical exam
Yes 34 (30.6) 48 (30.2) 0.94 15 (42.9) 65 (27.9) 0.08
No 77 (69.4) 111 (69.8) 20 (57.1) 168 (72.1)
Marital Status
Married/Cohabiting 48 (42.9) 74 (46) 0.61 15 (42.8) 106 (44.9) 0.82
Widowed/Single/Separated 64 (57.1) 87 (54) 20 (57.1) 130 (55.1)
Monthly income (1US = 10E)
<E500 or None 38 (33.9) 61 (38.1) 0.03 11 (31.4) 88 (37.5) 0.43
E500–1200 38 (33.9) 32 (20) 12 (34.3) 56 (23.8)
>E1201 36 (32.1) 67 (41.9) 12 (34.3) 91 (38.7)
Highest educational level
Primary/No school 33 (29.5) 25 (15.5) <0.01 6 (17.1) 50 (21.2) 0.08
Secondary 70 (62.5) 90 (55.9) 26 (74.3) 134 (56.8)
Tertiary 9 (8) 46 (28.6) 3 (8.6) 52 (22.0)
Employment status
Employed/Self-employed/Partially 75 (67) 93 (59.2) 0.20 26 (74.3) 140 (60.3) 0.12
Unemployed/Student 37 (33) 64 (40.8) 9 (25.7) 92 (39.7)
Occupation
Laborer 31 (38.7) 35 (32.7) 0.68 12 (44.4) 52 (32.7) 0.13
Skilled worker/Clerical 29 (36.3) 44 (41.1) 6 (22.2) 67 (42.1)
Professional 20 (25) 28 (26.2) 9 (33.3) 40 (25.2)
Religion
Christian 109 (97.3) 157 (98.7) 0.40 35 (100) 229 (97.9) 1.00
Other (Traditional, Muslim, None) 3 (2.7) 2 (1.3) 0 (0) 5 (2.1)
Smoking status
Never smoked 106 (94.6) 157 (97.5) 0.22 35 (100) 226 (95.8) 0.37
Former/Current smoker 6 (5.4) 4 (2.5) 0 (0) 10 (4.2)
Drink alcohol?
Yes 12 (10.9) 11 (6.9) 0.25 4 (11.8) 19 (8.2) 0.51
No 98 (89.1) 148 (93.1) 30 (88.2) 214 (91.8)
Numbers may not always add up to total number due to missing responses. VIA data were available for 271 women but HIV status was not available for 3 of
these women
Significant at p<0.05 are in bold
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N (%) N (%) N (%)
Age at first sexual intercourse
≤17 17 (48.6) 93 (39.4) 110 (40.6) 0.49
18–23 17 (48.6) 129 (54.7) 146 (53.9)
≥24 1 (2.9) 14 (5.9) 15 (5.5)
Number of lifetime sexual partners
1 4 (11.4) 66 (28.0) 70 (25.8) 0.03
≥2 31 (88.6) 170 (72.0) 201 (74.2)
Mean number of children 2 ± 1.44 2.1 ± 1.90 2.1 ± 1.84 0.64
Age at first child
≤17 13 (37.1) 84 (35.6) 97 (35.8) 0.36
18–23 20 (57.1) 120 (50.8) 140 (51.7)
≥24 2 (5.7) 32 (13.6) 34 (12.5)
Condom use
Do not use condoms 5 (14.3) 50 (21.2) 55 (20.3) 0.40
Sometimes/Most times/Non-Regular partner only 23 (65.7) 127 (53.8) 150 (55.3)
100% of the time 7 (20.0) 59 (25.0) 66 (24.4)
Condom use at last sex
Yes 17 (48.6) 128 (54.5) 145 (53.7) 0.52
No 18 (51.5) 107 (45.5) 125 (46.3)
Ever been raped
Yes 1 (2.9) 15 (6.4) 16 (5.9) 0.70
No 34 (97.1) 221 (93.6) 255 (94.1)
Sex in exchange for money
Yes 1 (2.9) 3 (1.3) 4 (1.5) 0.43
No 34 (97.1) 233 (98.7) 267 (98.5)
Sex in exchange for food or housing/rent?
Yes 1 (2.9) 3 (1.3) 4 (1.5) 0.43
No 34 (97.1) 233 (98.7) 267 (98.5)
History of any of the following STIs
Warts, gonorrhea, syphilis, herpes 15 (42.9) 60 (26.2) 75 (28.8) 0.05
None 20 (57.1) 169 (73.8) 189 (71.6)
Anal sex in the past 12 months
Yes 2 (5.7) 11 (4.7) 13 (4.8) 0.68
HIV Status
Positive 25 (73.5) 84 (34.9) 109 (40.7) <0.01
Negative 9 (26.5) 150 (64.1) 159 (59.3)
Numbers may not always add up to total number due to missing responses
Significant at p<0.05 are in bold
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presence of cervical lesions. Women who had had a pre-
vious cervical exam were 2.5 times more likely to have
cervical lesions (OR 2.53, CI 1.06–6.05) than women
who had not had a cervical exam.Discussion
HIV was found to be a significant predictor for presence
of cervical lesions in both the age-adjusted and the fully-
adjusted logistic models. This is not a surprising finding
since HPV, especially high-risk (hr) HPV types, have
Table 3 Multivariable association of sociodemographic
characteristics and sexual and reproductive history with













Had previous cervical exam




Widowed/Single 1.01 (0.48–2.09) 0.83 (0.37–1.90)
Monthly income (1US = 10E)
<E500 or None Referent Referent
E500–1200 1.77 (0.72–4.33) 0.78 (0.19–3.14)
>E1201 1.11 (0.46–2.68) 0.75 (0.19–2.93)
Highest educational level
Primary/No School Referent Referent
Secondary 1.50 (0.57–3.93) 2.47 (0.84–7.31)
Tertiary 0.45 (0.11–1.91) 1.11 (0.20–6.34)
Employment status
Employed/Self/Partially 2.33 (0.99–5.47) 3.12 (0.81–12.11)
Unemployed/Student Referent Referent
Age at first sexual intercourse
≤17 2.30 (0.28–18.81) 0.85 (0.08–9.65)
18–23 1.65 (0.20–13.44) 0.69 (0.06–7.50)
≥24 Referent Referent
Number of lifetime sexual partners
1 Referent Referent
≥2 3.00 (1.02–8.85) 2.42 (0.65–9.08)
History of any of the following STIs
Warts, Gonorrhea,
Syphilis, Herpes
2.16 (1.04–4.50) 1.42 (0.63–3.22)
No Referent Referent
Condom use
Not used Referent Referent
Sometimes/most times/
Non-regular partner only
1.61 (0.56–4.64) 1.11 (0.34–3.64)
100% of the time 1.11 (0.33–3.78) 0.76 (0.20–2.96)
aOdds Ratio (OR) for each socio-demographic and reproductive variable
adjusted for age
bFully adjusted model including all socio-demographic and
reproductive variables
The boldface odds ratios are significant
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infected women [6, 7, 19, 20]. Although some of the
women in our study were recruited from ART clinics,
we did not collect data on time and adherence to ART,
or on CD4 count, so we are not able to relate cervical le-
sions to immune status of the women. The rates of cer-
vical lesions obtained in our study are similar to those
found in studies conducted by Yamada et al. in Kenya
that reported 21.0% low grade squamous intraepithelial
lesions (LSIL) in HIV positive women versus 6.9% in
HIV negative women [20], and by Leroy et al. in Rwanda
that reported SILs of 24.3% in HIV positive and 6.5% in
HIV negative women [21]. The overall percent of cer-
vical lesions (12.7%) obtained in our study is also similar
to the 11.7% cervical dysplasia rate reported by La Ruche
et al. among women in the Ivory Coast [22].
With regard to risk factors associated with cervical
lesions we found in our age-adjusted model that the
number of lifetime sexual partners and a history of
STI(s) were significant predictors of cervical lesions.
Approximately 74% of the women reported two or more
lifetime sexual partners with significantly more HIV
positive women (88.6%) reporting two or more lifetime
sexual partners compared to HIV negative women
(72.0%). Also, STIs occurred fairly regularly among the
women with 28.8% reporting a history of STIs. A signifi-
cantly higher proportion of VIA positive women (42.9%)
reported history of STIs compared to VIA negative
women (26.2%). Other studies have reported number of
sexual partners [16, 23] and STIs [22] as predictors of
cervical lesions. Condom use was low or irregular in this
population with 20.3% of women reporting no condom
use and only 24.4% reporting consistent condom use;
the majority of women (55.3%) reported inconsistent
condom use. Condom use would be beneficial in pro-
tecting against STIs although it is not fully protective
against HPV infection which can be transmitted by skin
to skin contact.
In the fully adjusted model, previous cervical exam
was found to be significantly associated with the pres-
ence of cervical lesions. This finding may relate to the
fact that women with cervical lesions were more likely
to report previous STI(s) or were more likely to be HIV
positive and to have received cervical examination. No
effort was made in the study to identify or recruit
women with prior abnormal lesions. The women were
invited to participate in the study as they came into the
clinic and only those who agreed and gave informed
consent were enrolled. Therefore, there was no recruit-
ment bias according to presence or absence of cervical
lesion. Rather, there may be self-selection bias from
women who self-selected to participate in the study,
were more exposed to the health care system, and had
prior cervical exams. Women who newer to the clinic
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association of previous cervical exam with the presence
of cervical lesions may also be explained by other un-
accounted factors.
This study has other limitations which must be con-
sidered in interpreting the results. First it was a cross-
sectional study and so does not allow for determination
of temporal relationships. Secondly, no ART or CD4
data were collected, and no HPV genotyping was done.
These data would have helped in interpreting the results
and in further analyses. VIA lesions were not categorized
into low-grade SIL or high grade SIL which limits com-
parison with other published papers. However, this is the
first study to estimate cervical lesions using a low re-
source but highly effective method of screening for cer-
vical lesions in Swaziland.Conclusion
The findings that number of sexual partners and history
of STI are predictors of cervical lesions can be used to
develop and conduct interventions to decrease number
of sex partners and protect against STIs among the
women. The high prevalence of HIV infection in
Swaziland and the strong association between HIV and
HPV infections and cervical lesions, highlight the need
for substantial scale-up of cervical screening, not only by
VIA but also by HPV genotyping, to decrease the high
rate of CC in the country.
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